Skip to main content
Fachgebiete
Automobil + Motoren Bauwesen + Immobilien Business IT + Informatik Elektrotechnik + Elektronik Energie + Nachhaltigkeit Finance + Banking Management + Führung Marketing + Vertrieb Maschinenbau + Werkstoffe Versicherung + Risiko
DE
EN
Bücher
Zeitschriften
Themenseiten
Organisationspsychologie Projektmanagement Marketing Smart Manufacturing
Weitere Formate
Podcasts Webinare Technik Webinare Wirtschaft Kongresse Veranstaltungskalender Awards
Jetzt Einzelzugang starten
Zugang für Unternehmen
Referenzkunden
SLX-Digitalkonferenz: Zukunftswerkstatt 2024

Mehr Umsatz mit Top-Kontakten

Am 7. Mai erfahren Sie, wie Vertriebsteams Leadgenerierung, Leadnurturing und Leadstrategien effizient steuern können.
Erweiterte Suche
Anmelden
nach oben
Erschienen in:
Nonautonomous Dynamical Systems in the Life Sciences Kapitel lesen Erstes Kapitel lesen

2013 | OriginalPaper | Buchkapitel

8. Viral Kinetic Modeling of Chronic Hepatitis C and B Infection

verfasst von : Eva Herrmann, Yusuke Asai

Erschienen in: Nonautonomous Dynamical Systems in the Life Sciences

Verlag: Springer International Publishing

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Chronic infection with hepatitis C or hepatitis B virus are important world-wide health problems leading to long-term damage of the liver. There are, however, treatment options which can lead to viral eradication in hepatitis C or long-term viral suppression in hepatitis B in some patients. Nevertheless, there is still room for improvement. Mathematical compartment models based on ordinary differential equation systems have successfully been applied to improve antiviral treatment. Here, we illustrate how mathematical and statistical analysis of such models influenced clinical research and give an overview on the most important models for hepatitis C and hepatitis B viral kinetics.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Jetzt informieren
Vorheriges Kapitel Mathematical Concepts in Pharmacokinetics and Pharmacodynamics with Application to Tumor Growth
Nächstes Kapitel Some Classes of Stochastic Differential Equations as an Alternative Modeling Approach to Biomedical Problems
Literatur
1.
B.S. Adiwijaya, E. Herrmann, B. Hare, T. Kieffer, C. Lin, A.D. Kwong, V. Garg, J.C. Randle, C. Sarrazin, S. Zeuzem, P.R. Caron, A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants. PLoS Comput. Biol. 6, e1000745 (2010)CrossRef
2.
Y. Asai, E. Herrmann, P.E. Kloeden, Stable integration of stiff random ordinary differential equations. Stoch. Anal. Appl. 31, 293–313 (2013)CrossRefMATHMathSciNet
3.
F.C. Bekkering, J.T. Brouwer, B.E. Hansen, S.W. Schalm, Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin. J. Hepatol. 34, 435–440 (2001)CrossRef
4.
S.P. Chakrabarty, J.M. Murray, Modelling hepatitis C virus infection and the development of hepatocellular carcinoma. J. Theor. Biol. 305, 24–29 (2012)CrossRefMathSciNet
5.
A. Chatterjee, J. Guedj, A.S. Perelson, Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents? Antivir. Ther. 17, 1171–1182 (2012)CrossRef
6.
V. Colizza, A. Barrat, M. Barthélemy, A. Vespignani, The modeling of global epidemics: stochastic dynamics and predictibility. Bull. Math. Biol. 68, 1893–1921 (2006)CrossRefMathSciNet
7.
H. Dahari, J. Guedj, A.S. Perelson, T.J. Layden, Hepatitis C viral kinetics in the era of direct acting antiviral agents and IL28B. Curr. Hepat. Rep. 10, 214–227 (2011)CrossRef
8.
H. Dahari, E. Shudo, R.M. Ribeiro, A.S. Perelson, Mathematical modeling of HCV infection and treatment. Meth. Mol. Biol. 510, 439–453 (2009)CrossRef
9.
N.M. Dixit, J.E. Layden-Almer, T.J. Layden, A.S. Perelson, Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. Nature 432, 922–924 (2004)CrossRef
10.
J. Guedj, R. Thiébaut, D. Commenges, Maximum likelihood estimation in dynamical models of HIV. Biometrics 63, 1198–1206 (2007)CrossRefMATHMathSciNet
11.
J. Guedj, A.U. Neumann, Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics. J. Theor. Biol. 267, 330–340 (2010)CrossRefMathSciNet
12.
E. Herrmann, J.H. Lee, G. Marinos, M. Modi, S. Zeuzem, Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon. Hepatology 37, 1351–1358 (2003)CrossRef
13.
E. Herrmann, C. Sarrazin, Hepatitis C viral kinetics. J. Gastroenterol. Hepatol. 19, S133–S137 (2004)CrossRef
14.
W.O. Kermack, A.G. McKendrick, Contributions to the mathematical theory of epidemics I, Reprint from the Proc. Roy. Soc. Lond. Ser. A 115, 700–721 (1927), in Bull. Math. Biol. 53, 33–55 (1991)
15.
U. Mihm, H.L. Chan, S. Zeuzem, A.M. Chim, A.Y. Hui, V.W. Wong, J.J. Sung, E. Herrmann, Virodynamic predictors of response to pegylated interferon and lamivudine combination treatment of hepatitis B e antigen-positive chronic hepatitis B. Antivir. Ther. 13, 1029–1037 (2008)
16.
J.D. Murray, Mathematical Biology: I. An Introduction, 3rd edn. Interdisciplinary Applied Mathematics, vol. 17 (Springer, Berlin, 2001)
17.
S. Naggie, A. Osinusi, A. Katsounas, R. Lempicki, E. Herrmann, A.J. Thompson, P.J. Clark, K. Patel, A.J. Muir, J.G. McHutchison, J.F. Schlaak, M. Trippler, B. Shivakumar, H. Masur, M.A. Polis, S. Kottilil, Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response. Hepatology 56, 444–454 (2012)CrossRef
18.
J. Nakabayshi, A compartmentalization model for hepatitis C virus replication: An appropriate distribution of HCV RNA for effective replication. J. Theor. Biol. 300, 110–117 (2012)CrossRef
19.
A.U. Neumann, N.P. Lam, H. Dahari, D.R. Gretch, T.E. Wiley, T.J. Layden, A.S. Perelson, Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282, 103–107 (1998)CrossRef
20.
M.A. Nowak, S. Bonhoeffer, A.M. Hill, R. Boehme, H.C. Thomas, H. McDade, Viral dynamics in hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 93, 4398–4402 (1996)CrossRef
21.
M.A. Nowak, R.M. May, Virus Dynamics (Oxford University Press, New York, 2000)MATH
22.
A.S. Perelson, E. Herrmann, F. Micol, S. Zeuzem, New kinetic models for the hepatitis C virus. Hepatology 42, 749–754 (2005)CrossRef
23.
K.A. Powers, N.M. Dixit, R.M. Ribeiro, P. Golia, A.H. Talal, A.S. Perelson, Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2b. Sem. Liver Dis. 23(Suppl 1), 13–18 (2003)
24.
R.M. Ribeiro, G. Germanidis, K.A. Powers, B. Pellegrin, P. Nikolaidis, A.S. Perelson, J.M. Pawlotsky, Hepatitis B virus kinetics under therapy sheds light on differences between e-antigen positive and negative infection. J. Infect. Dis. 202, 1309–1318 (2010)CrossRef
25.
R.M. Ribeiro, H. Li, S. Wang, M.B. Stoddard, G.H. Learn, B.T. Korber, T. Bhattacharya, J. Guedj, E.H. Parrish, B.H. Hahn, G.M. Shaw, A.S. Perelson, Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate. Plos Pathogens 8, e1002881 (2012)CrossRef
26.
L. Rong, R.M. Ribeiro, A.S. Perelson, Modeling quasispecies and drug resistance in hepatitis C patients treated with a protease inhibitor. Bull. Math. Biol. 74, 1789–1817 (2012)CrossRefMATHMathSciNet
27.
C. Sarrazin, S. Schwendy, B. Möller, N. Dikopoulos, P. Buggisch, J. Encke, G. Teuber, T. Goeser, R. Thimme, H. Klinker, W.O. Boecher, E. Schulte-Frohlinde, R. Prinzing, E: Herrmann, S. Zeuzem, T. Berg, Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24–72 weeks. Gastroenterology 141, 1656–1664 (2011)
28.
E. Snoeck, P. Chanu, M. Lavielle, P. Jacqmin, E.N. Jonsson, K. Jorga, T. Goggin, J. Grippo, N.L. Jumbe, N. Frey, A comprehensive hepatitis C viral kinetic model explaining cure. Clin. Pharmacol. Therapeut. 87, 706–713 (2010)CrossRef
29.
V. Soriano, A.S. Perelson, F. Zoulim, Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses? J. Antimicrob. Chemother. 62, 1–4 (2008)CrossRef
30.
V.A. Sypsa, K. Mimidis, N.C. Tassopoulos, D. Chrysagis, T. Vassiliadis, A. Moulakakis, M. Raptopoulou, C. Haida, A. Hatzakis, A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative. Hepatology 42, 77–85 (2005)CrossRef
31.
M. Soschinsky, Plausibility of predicted steady states in simulations with HCV kinetic models and prognostic significance of first phase viral kinetics. Medical Doctoral Thesis, Goethe University Frankfurt, Department of Medicine, 2013
32.
D.J. Suh, S.H. Um, E. Herrmann, J.H. Kim, Y.S. Lee, H.J. Lee, M.S. Lee, Y.S. Lee, W. Bao, P. Lopez, H.C. Lee, C. Avila, S. Zeuzem, Early viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis B. Antimicrob. Agents Chemother. 54, 1242–1247 (2010)CrossRef
33.
S. Susser, C. Welsch, Y. Wang, M. Zettler, F.S. Domingues, U. Karey, E. Hughes, R. Ralston, X. Tong, E. Herrmann, S. Zeuzem, C. Sarrazin, Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients. Hepatology 50, 1709–1718 (2011)CrossRef
34.
K.H. Tang, E. Herrmann, H. Cooksley, N. Tatman, S. Chokshi, R. Williams, S. Zeuzem, N.V. Naoumov, Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy. J. Hepatol. 43, 776–782 (2005)CrossRef
35.
S.W. Vidurupola, L.J.S. Allen, Basic stochastic models for viral infection within a host. Math. Biosci. Eng. 9, 915–935 (2012)CrossRefMATHMathSciNet
36.
S. Zeuzem, E. Herrmann, J.H. Lee, J. Fricke, A.U. Neumann, M. Modi, G. Colucci, W.K. Roth, Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a. Gastroenterology 120, 1438–1447 (2001)CrossRef
Metadaten
Titel
Viral Kinetic Modeling of Chronic Hepatitis C and B Infection
verfasst von
Eva Herrmann
Yusuke Asai
Copyright-Jahr
2013
Buch
Nonautonomous Dynamical Systems in the Life Sciences

Print ISBN: 978-3-319-03079-1

Electronic ISBN: 978-3-319-03080-7

Copyright-Jahr: 2013

DOI
https://doi.org/10.1007/978-3-319-03080-7_8